CL.CN

Cresco Labs Inc.
Canadian SecCADEQUITY Healthcare DELAYED
Last price
1.13
▲ 0.05 (4.63%)
MARKET ·

Price

Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
1.08
Prev close
1.08
Day high
1.13
Day low
1.07
Volume
95.06K
Market cap
$420.75M
P/E (TTM)
52W range
0.89 – 3.12

Day trading desk

Current session · delayed
Gap from prior close
0.00%
Prior close 1.08
VWAP
1.10
+2.51% from price
Relative volume
1.29×
Normal
Session range
5.61%
1.07 – 1.13
Position in range
100%
Near session high
ATR (14D)
0.07
6.38% of price
Prior day high
1.14
PDH
Prior day low
1.08
PDL
Bid / ask spread
Quote not published
Session volume
131.63K
Avg 101.78K

VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.

Trailing performance

Price return · vs SPY
Returnvs SPY
1W
+2.73% +4.1%
1M
+13.00% +9.3%
3M
-5.04% -8.1%
6M
-13.74% -24.8%
YTD
-31.93% -44.2%
1Y
-25.17% -45.2%
3Y
-23.13% -97.3%
5Y

Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.

Unusual options activity

Account required
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
Free account required

Contracts trading at or above their open interest, ranked by notional and where the print landed.

Free account

5 more panels on CL.CN open with an account.

Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.

Insider net activity

6m · Form 4 rollup
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
Net transactions
0
Buys less sells
Sell : buy shares
Not enough filings
Insider-held shares
7.64M
Total on file

Insider transactions

Account required
DateInsiderAction SharesValueHeld
Aug 15, 26
Bachtell (Charles Ian)
Director of Issuer
EXERCISE 301.71K $232.62K Direct
Aug 15, 26
Butler (Gregory Randolph)
Senior Officer of Issuer
EXERCISE 301.71K $232.62K Direct
Aug 15, 26
Marburger (Zachary Austen)
Senior Officer of Issuer
EXERCISE 154.70K $119.27K Direct
Jun 16, 26
Butler (Gregory Randolph)
Senior Officer of Issuer
SELL 3.00K $2.46K Direct
Jun 15, 26
Butler (Gregory Randolph)
Senior Officer of Issuer
SELL 3.00K $2.46K Direct
Jun 15, 26
Butler (Gregory Randolph)
Senior Officer of Issuer
SELL 1.00K $821 Direct
Jun 12, 26
Butler (Gregory Randolph)
Senior Officer of Issuer
SELL 5.64K $4.63K Direct
Jun 12, 26
Butler (Gregory Randolph)
Senior Officer of Issuer
SELL 1.04K $855 Direct
Jun 12, 26
Butler (Gregory Randolph)
Senior Officer of Issuer
SELL 314 $270 Direct
Jun 11, 26
Butler (Gregory Randolph)
Senior Officer of Issuer
SELL 7.70K $6.69K Direct
Jun 10, 26
Butler (Gregory Randolph)
Senior Officer of Issuer
SELL 3.50K $3.22K Direct
Jun 9, 26
Butler (Gregory Randolph)
Senior Officer of Issuer
SELL 5.00K $4.75K Direct
Jun 8, 26
Butler (Gregory Randolph)
Senior Officer of Issuer
SELL 5.00K $4.70K Direct
May 28, 26
Butler (Gregory Randolph)
Senior Officer of Issuer
SELL 2.50K $2.30K Direct
What this is, and what it is not

These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.

A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.

This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.

Free account required

Officer and director trades in their own stock, straight from Form 4 filings.

Insider holders

9 reporting
NameRelationShares heldLatest
Bachtell (Charles Ian)
Director of Issuer 1.32M Exercise of rights
Butler (Gregory Randolph)
Senior Officer of Issuer 311.49K Exercise of rights
Corcoran (Gerald Francis)
Director of Issuer 512.84K Acquisition or disposition in the public market
Demchenko (Angela)
Senior Officer of Issuer 116.11K Exercise of rights
Lustig (Marc)
Director of Issuer 36.78M Exercise of rights
Marburger (Zachary Austen)
Senior Officer of Issuer 454.10K Exercise of rights
Sampson (Robert Malcom)
Director of Issuer 4.02M Acquisition or disposition in the public market
Schetz (John Patrick)
Senior Officer of Issuer 75.83K Acquisition or disposition in the public market
Schuler (Sharon Elizabeth)
Senior Officer of Issuer 70.35K Exercise of rights

Fundamentals

TTM · reported
Market cap$420.75M
Enterprise value$884.55M
Revenue (TTM)$651.13M
Gross profit$325.08M
EBITDA$111.14M
Net income$-100.92M
EPS (TTM)$-0.39
Free cash flow$24.95M
Total cash$32.87M
Total debt$592.02M
Book value / share$1.34
Shares outstanding355.59M
Float346.25M
Short % of float0.00%
Dividend yield
Beta (5Y)1.72

Valuation & profitability ratios

Account required
Trailing P/E
Forward P/E-19.16
PEG ratio
Price / sales
Price / book0.84
EV / revenue1.36
EV / EBITDA7.96
Gross margin49.93%
Operating margin7.71%
Profit margin-15.50%
Return on equity-36.06%
Return on assets3.00%
Debt / equity224.80
Current ratio1.78
Free account required

Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.

Financial statements

As reported · 4 years · 6 quarters
Blank means not reported, not zero
Line item2025202420232022YoY
Total revenue $655.85M$724.34M$770.88M$842.68M -9.5%
Operating revenue $655.85M$724.34M$770.88M$842.68M -9.5%
Cost of revenue $331.28M$359.89M$408.52M$435.67M -7.9%
Gross profit $324.57M$364.45M$362.37M$407.01M -10.9%
Selling, general & admin $247.45M$254.84M$274.63M$350.65M -2.9%
Total operating expense $247.62M$255.17M$299.49M$350.08M -3.0%
Operating income $76.94M$109.28M$62.88M$56.93M -29.6%
Net interest income -$56.28M-$54.60M-$60.82M-$57.84M -3.1%
Pre-tax income -$95.42M-$10.62M-$146.90M-$126.91M -798.9%
Tax provision $44.62M$49.87M$32.95M$88.94M -10.5%
Net income -$135.41M-$74.44M-$175.52M-$212.05M -81.9%
Net income to common -$135.41M-$74.44M-$175.52M-$212.05M -81.9%
Basic EPS -0.38-0.17-0.53-0.71 -119.0%
Diluted EPS -0.38-0.17-0.53-0.71 -119.0%
EBIT -$35.39M$46.91M-$83.28M-$68.39M -175.5%
EBITDA $20.34M$112.90M-$13.97M-$10.66M -82.0%
Basic shares 355.01M348.60M339.71M298.16M +1.8%
Diluted shares 355.01M348.60M339.71M298.16M +1.8%

Options analytics

Account required
Put / call volume
Put / call open interest
Positioning, not flow
Max pain
ATM implied vol
Nearest strike to spot
Skew (10% OTM)
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
Heaviest put OI

Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.

Free account required

Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.

Earnings

History & consensus estimates
Reported vs expected · EPS
QuarterEst.ActualSurprise
Jun 2026 -0.030.06 +286.7%
Mar 2026 -0.04-0.04 +5.8%
Dec 2025 -0.03-0.03 +10.4%
Sep 2025 -0.040.01 +120.4%
Forward consensus
PeriodEPSAnalystsRevenueGrowth
Current quarter -0.03 1 $173.66M +5.3%
Next quarter -0.03 1 $173.89M +7.6%
Current year -0.04 1 $672.19M +2.5%
Next year -0.04 1 $697.47M +3.8%

Analyst targets & ownership

Account required
Mean target$2.49
High target$2.70
Low target$2.27
Implied upside120.62%
Analyst count4
ConsensusSTRONG BUY
Strong buy / Buy1 / 5
Hold0
Sell / Strong sell0 / 0
Held by insiders2.05%
Held by institutions3.45%
Institutions holding12
Free account required

Price targets, consensus spread, insider and institutional ownership.

Moving averages & technicals

Computed from 2Y daily closes
SMA 10
1.08
+4.63% from price
SMA 20
1.01
+11.38% from price
SMA 50
1.07
+5.83% from price
SMA 100
1.19
-5.34% from price
SMA 200
1.32
-14.36% from price
EMA 12
1.07
+5.82% from price
EMA 26
1.05
+7.24% from price
EMA 50
1.09
+4.10% from price
RSI (14)
56.8
Neutral
MACD (12,26,9)
0.01
Hist 0.02
ATR (14)
0.07
6.38% of price
Realised vol 30D
78.4%
Annualised
Bollinger upper
1.17
20, 2σ
Bollinger lower
0.86
20, 2σ
50 / 200 cross
Death
1.07 vs 1.32
Trend bias
Below 200
-14.36%

Options chain

Account required
ExpirySpot 1.13
Calls
StrikeLastBidAskVolOIIV
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
Puts
StrikeLastBidAskVolOIIV
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
Free account required

Every listed expiry, both sides of the book, with volume, open interest and implied volatility.

Risk profile

Daily returns · 1Y window
Beta vs SPY
0.68
Less volatile than market
Correlation to SPY
0.06
Largely independent
Realised vol 30D
78.4%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-67.3%
Peak to trough
Max drawdown 5Y
-95.3%
Peak to trough
ATR 14
0.07
6.38% of price
Beta (reported)
1.72
5Y monthly, from filing

Short interest

Semi-monthly exchange report · lags by ~2 weeks
Shares short
9.42K
Prior 234.74K
Change vs prior
-96.0%
Shorts covering
% of float
0.00%
Normal
% of shares out
0.00%
Against total outstanding
Days to cover
0.1
Liquid
Float
346.25M
Freely tradeable shares

Exchanges publish short interest twice a month with a settlement lag, so this is roughly two weeks behind. Days to cover divides shares short by average daily volume — it estimates how long covering would take, not whether it will happen.

Rating changes

29 on file
DateFirm ActionFromTo
Aug 12, 24 Needham MAINTAINED Hold
Jun 12, 24 Zuanic & Associates INITIATED Overweight
May 16, 24 Wedbush MAINTAINED Outperform Outperform
May 16, 24 Needham MAINTAINED Hold Hold
Mar 14, 24 Roth MKM MAINTAINED Neutral Neutral
Mar 20, 23 Wedbush MAINTAINED Outperform
Feb 24, 23 Cantor Fitzgerald MAINTAINED Overweight
Dec 30, 22 Cantor Fitzgerald MAINTAINED Overweight
Dec 20, 22 Cowen & Co. DOWNGRADE Outperform Market Perform
Dec 2, 22 Wedbush INITIATED Outperform
Aug 18, 22 Piper Sandler MAINTAINED Overweight
Aug 18, 22 Cantor Fitzgerald MAINTAINED Overweight

Dividends & splits

Declared · from the issuer
Forward rate
Forward yield
5-year avg yield
Payout ratio0.00%
Ex-dividend date
Next pay date
Last split1:812.63
Split dateDec 3, 2018

PRIVATE STRATEGY · BY QUALIFICATION

The same data. A different seat.

The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.